TAYEBATI, Seyed Khosrow
 Distribuzione geografica
Continente #
NA - Nord America 19.258
EU - Europa 12.061
AS - Asia 10.740
SA - Sud America 1.228
AF - Africa 156
Continente sconosciuto - Info sul continente non disponibili 47
OC - Oceania 34
Totale 43.524
Nazione #
US - Stati Uniti d'America 18.363
CN - Cina 4.554
RU - Federazione Russa 2.911
SG - Singapore 2.444
IT - Italia 2.273
HK - Hong Kong 1.970
PL - Polonia 1.750
BR - Brasile 1.049
UA - Ucraina 1.045
DE - Germania 1.009
SE - Svezia 770
CA - Canada 758
FR - Francia 757
GB - Regno Unito 486
FI - Finlandia 420
KR - Corea 409
TR - Turchia 388
VN - Vietnam 355
IE - Irlanda 245
IN - India 150
MX - Messico 97
NL - Olanda 88
AR - Argentina 66
IR - Iran 63
ZA - Sudafrica 63
CH - Svizzera 54
PK - Pakistan 52
JP - Giappone 50
CZ - Repubblica Ceca 47
BD - Bangladesh 44
EU - Europa 44
IQ - Iraq 43
ID - Indonesia 33
ES - Italia 32
BE - Belgio 30
EC - Ecuador 29
AU - Australia 28
GR - Grecia 27
MA - Marocco 25
SA - Arabia Saudita 24
PE - Perù 22
TW - Taiwan 22
CO - Colombia 20
AT - Austria 19
LT - Lituania 19
MY - Malesia 16
UZ - Uzbekistan 16
AE - Emirati Arabi Uniti 15
RO - Romania 15
EG - Egitto 13
TH - Thailandia 12
VE - Venezuela 11
CL - Cile 10
EE - Estonia 10
PY - Paraguay 10
AZ - Azerbaigian 9
DZ - Algeria 9
IL - Israele 9
PH - Filippine 9
TN - Tunisia 9
AL - Albania 8
DK - Danimarca 8
JM - Giamaica 8
PA - Panama 8
UY - Uruguay 8
GH - Ghana 7
JO - Giordania 7
KZ - Kazakistan 7
NO - Norvegia 7
HU - Ungheria 6
KE - Kenya 6
KG - Kirghizistan 6
NG - Nigeria 6
NZ - Nuova Zelanda 5
OM - Oman 5
PT - Portogallo 5
RS - Serbia 5
TT - Trinidad e Tobago 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
HN - Honduras 4
LV - Lettonia 4
AM - Armenia 3
BO - Bolivia 3
CM - Camerun 3
ET - Etiopia 3
GA - Gabon 3
GE - Georgia 3
GT - Guatemala 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
NP - Nepal 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
AD - Andorra 2
HR - Croazia 2
LB - Libano 2
LK - Sri Lanka 2
LY - Libia 2
MO - Macao, regione amministrativa speciale della Cina 2
Totale 43.501
Città #
Jacksonville 2.192
Hong Kong 1.955
Warsaw 1.553
Fairfield 1.321
Ashburn 1.313
Chandler 1.229
Woodbridge 1.162
Boardman 1.013
Houston 895
Singapore 887
Wilmington 783
Ann Arbor 626
Seattle 592
Nanjing 585
Beijing 569
Toronto 558
Cambridge 448
The Dalles 385
Seoul 369
Tongling 348
Lawrence 336
Princeton 336
San Mateo 331
Los Angeles 328
Columbus 307
Istanbul 307
Shanghai 301
Camerino 291
Ogden 271
Dearborn 240
Dublin 229
Nanchang 223
New York 210
Dallas 208
Helsinki 201
Centro 188
Guangzhou 173
Dong Ket 160
Moscow 160
Buffalo 159
Kraków 146
Zhengzhou 146
Jiaxing 134
Milan 118
Shenyang 118
Kunming 113
Lachine 112
Düsseldorf 107
London 105
Munich 101
São Paulo 94
Tianjin 94
Hebei 90
Redondo Beach 89
Chicago 83
Philadelphia 78
Bremen 76
Ho Chi Minh City 75
Redwood City 69
Wuhan 68
Rome 67
Changsha 62
Hangzhou 55
San Diego 54
Vinnytsia 54
Frankfurt am Main 52
Jinan 52
Santa Clara 49
Rio de Janeiro 48
Falls Church 45
Johannesburg 44
Kocaeli 44
Tokyo 44
Denver 41
Hefei 41
Montreal 41
Norwalk 40
Hanoi 37
Shenzhen 37
Council Bluffs 36
Chennai 35
Lanzhou 35
Stockholm 35
Orange 34
Mexico City 33
Orem 33
Venezia 33
Atlanta 32
Verona 32
Brooklyn 31
Detroit 31
Wuxi 31
Phoenix 30
Turku 29
Brussels 26
Athens 25
Bern 25
Brno 25
Mumbai 25
Yiwu 25
Totale 27.306
Nome #
Modified expression of peripheral blood lymphocyte muscarinic cholinergic receptors in asthmatic children. 1.184
Effetti neuroprotettivi del Nerve Growth Factor somministrato come collirio in bambini e giovani adulti con deficits visivi indotti da gliomi delle vie ottiche 667
A multidisciplinary approach to study the brain injury in Diet-Induced (DIO) rats 437
Metabolic effects of tart Cherries Supplementation in an animal model of obesity 415
Anatomia del Gray, I Fondamenti 354
Choline and Choline alphoscerate Do Not Modulate Inflammatory Processes in the Rat Brain 339
Neurological Disorder, Stroke: Relevance of Preclinical Studies 328
Effects of Tart Cherry supplementation in Diet-Induced Obesity (DIO) rats. 325
Effect of treatment with the antioxidant alpha-lipoic (thioctic) acid on heart and kidney microvasculature in spontaneously hypertensive rats 321
Obesity-related nervous system injury: preliminary evidences in diet induced obesity (DIO) rats. 310
Neuroinflammatory Markers in Spontaneously Hypertensive Rat Brain: An Immunohistochemical Study 300
Obesity affects central nervous system: a multidisciplinary study in Diet-Induced Obesity (DIO) rats 297
Frontiers in Molecular Biosciences 296
EXPRESSION OF SINAPTO-VESICULAR PROTEINS IN BRAIN AREAS OF AN ANIMAL MODEL OF METABOLIC SYNDROME 293
Telerehabilitation: Review of the State-of-the-Art and Areas of Application 279
Identification of World Health Organisation ship's medicine chest contents by Anatomical Therapeutic Chemical (ATC) classification codes. 277
THE OBESE ZUCKER RATS: AN IN VIVO MODEL FOR STUDYING THE LIVER CARBONIC ANHYDRASE CAVII BIOLOGICAL ROLE 263
Process mining case study approach: Extraction of unconventional event logs to improve performance in Hospital Information Systems (HIS) 259
Brain alterations in high fat diet induced obesity: Effects of tart cherry seeds and juice 237
Astrogliosis in the brain of obese Zucker rat: a model of metabolic syndrome. 228
Comparative analysis of the medicinal compounds of the ship's "medicine chests" in European Union maritime countries. Need for improvement and harmonization 228
Editorial Board of Neurosurgery Cases and Reviews 227
Brain Activity of Thioctic Acid Enantiomers: In Vitro and in Vivo Studies in an Animal Model of Cerebrovascular Injury 226
Adrenergic receptor subtypes in human peripheral blood lymphocytes. 223
Guida alla Farmacia di Bordo 221
OBESITY-RELATED CEREBROVASCULAR INJURY IN OBESE ZUCKER RATS 221
Hypotensive effect of intravenous injection of tachykinins in conscious, freely moving spontaneously hypertensive and Wistar Kyoto rats. 218
Age-related changes of dopamine receptors in the rat hippocampus: a light microscope autoradiography study. 216
Report on market analysis and preventions need to provide medications for rural patients of Italy using ICT technologies 215
Comparative machine-learning approach: A follow-up study on type 2 diabetes predictions by cross-validation methods 213
Discovery of Highly Selective Imidazoline Receptor Ligands 211
Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications. 209
A novel clinical syndrome revealing a deficiency of the muscarinic M3 receptor. 208
THE PHARMACIST KNOWLEDGE AND COMPUTER SKILLS TOWARDS E-HEALTH. RESULTS OF A SURVEY AMONG ITALIAN COMMUNITY PHARMACISTS 207
PROTECTIVE ACITIVITY OF THE CHOLINE CONTAINING PHOSPHOLIPID CHOLINE ALPHOSCERATE, ON CEREBROVASCULAR TREE OF SPONTANEOUSLY HYPERTENSIVE RATS 207
Vesicular acetylcholine transporter (VAChT) in the brain of spontaneously hypertensive rats (SHR): effect of treatment with an acetylcholinesterase inhibitor 201
Cerebrovascular and blood-brain barrier morphology in spontaneously hypertensive rats: effect of treatment with choline alphoscerate. 201
(Neuro)transmitter systems in circulating immune cells: a target of immunopharmacological interventions? 200
Effects of acetylcholine precursors on inflammation in rat brain 199
Intranasal Drug Delivery to the Central Nervous System: Present Status and Future Outlook. 195
Effects of Prunus cerasus L. Seeds and Juice on Liver Steatosis in an Animal Model of Diet-Induced Obesity 193
Identification of dopamine plasma membrane and vesicular transporters in human peripheral blood lymphocytes 192
Vesicular monoamine transporter 1 mediates dopamine secretion in rat proximal tubular cells 191
ACTIVITY OF THIOCTIC ACID ENANTIOMERS ON SPINAL CORD CHANGES CONSEQUENT TO PERIPHERAL NERVE INJURY 184
Synthesis and muscarinic properties of (1S*,3R*,5R*)-trimethyl(1-methyl-6-oxabicyclo[3.1.0]hex-3-yl)methyl ammonium iodide 183
Obesity-related blood brain barrier changes in obese Zucker rats 183
Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmission 182
Use of frozen sections for the pharmacological characterization of compounds active on neurotransmitter receptors 182
Phospholipid and Lipid Derivatives as Potential Neuroprotective Compounds 182
Age-related changes in the brain of obese Zucker rat: Morphological and immunochemical analysis. 181
Ein neues klinisches Syndrom bedingt durch eine Defizienz des muskarinergen M3-Rezeptors: Trias aus bilateraler Mydriasis, Blasenentleerungsstörung und schlankem Habitus 177
Brain cholinergic dysfunction in obese Zucker LEPR(fa/fa) rats 177
Policies and challenges on the distribution of specialists and subspecialists in rural areas of Iran 176
Localization of the m5 muscarinic cholinergic receptor in rat circle of Willis and pial arteries 174
Changes in muscarinic cholinergic receptor expression in human peripheral blood lymphocytes in allergic rhinitis patients. 174
Age-related changes of muscarinic cholinergic receptor subtypes in the striatum of Fisher 344 rats. 174
Effects of cholinergic enhancing drugs on cholinergic transporters in the brain and peripheral blood lymphocytes of spontaneously hypertensive rats. 172
Occupancy by oral administration of nicardipine of L-type calcium channels in rat brain 170
Radioligand binding assay of M1-M5 muscarinic cholinergic receptor subtypes in human peripheral blood lymphocytes 170
Dopamine and vascular dynamics control: present status and future perspectives. 169
Dementias and cognitive disorders: New insights and approaches 169
ALLA SCOPERTA DEL RUOLO DELL’INVECCHIAMENTO E DEL SESSO NEI PROCESSI DEGENERATIVI FISIOLOGICI E PATOLOGICI DEI NERVI PERIFERICI. 169
Obesity and Metabolic Syndrome Affects the Cholinergic Transmission and Cognitive Functions 169
Muscarinic Thioligands with Cyclopentane Nucleus 168
Cardiovascular changes related to metabolic syndrome: Evidence in obese zucker rats 168
Postnatal development of dopamine D1-like and D2-like receptors in the rat kidney: a radioligand binding study 167
ACTIVITY OF CHOLINE ALPHOSCERATE ON CEREBROVASCULAR MORPHOLOGY AND INFLAMMATORY MARKERS IN SPONTANEOUSLY HYPERTENSIVE RATS 167
Potential dopamine-1 receptor stimulation in hypertension management. 165
Synthesis, Absolute Configuration, and Biological Profile of the Enantiomers of trans-[2-(2,6-Dimethoxypheoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (Mephendioxan), a Potent Competitive alpha 1A-Adrenoreceptor Antagonist 164
Pathways of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction. 164
Synthesis of 1-methyl-5-(pyrazol-3- and -5-yl- and 1, 2, 4-triazol-3- and 5-yl)-1, 2, 3, 6-tetrahydropyridine derivatives and their evaluation as muscarinic receptor ligands 164
Dopamine receptors in human platelets. 162
Spontaneously hypertensive rat as a model of vascular brain disorder: Microanatomy, neurochemistry and behavior. 162
Animal models of cognitive dysfunction. 161
Choline-containing phospholipids: relevance to brain functional pathways. 161
Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study 160
Evaluation of an Agonist Index: Affinity Ratio for Compounds Active on Muscarinic Cholinergic M2 Receptors 160
Heart morphology in Zucker-obese rats 160
Immunochemical and immunocytochemical characterization of cholinergic markers in human peripheral blood lymphocytes. 159
Muscarinic cholinergic receptors subtypes in rat cerebellar cortex: light microscope autoradiography of age-related changes 157
Glial fibrillary acidic protein and vimentin expression is regulated by glucocorticoids and neurotrophic factors in primary rat astroglial cultures 156
Age-related Changes in the Density of Muscarinic Cholinergic M1 and M2 Receptor Subtypes in Pyramidal Neurons or the rat Hippocampus 156
Postnatal development of dopamine receptor expression in rat peripheral blood lymphocytes. 156
Identification of adenosine A1 and A3 receptor subtypes in rat pial and intracerebral arteries. 155
Modulation Of Monoaminergic Transporters By Choline-Containing Phospholipids In Rat Brain. 155
Influence of dermal exposure to the pyrethroid insecticide deltamethrin on rat brain microanatomy and cholinergic/dopaminergic neurochemistry. 155
Effect of treatment with the cholinesterase inhibitor rivastigmine on vesicular acetylcholine transporter and choline acetyltransferase in rat brain. 153
BRAIN MORPHOLOGICAL ANALYSIS OF OBESE ZUCKER RAT: MODEL OF METABOLIC SYNDROME. 153
Dopamine D4 receptor in human peripheral blood lymphocytes: a radioligand binding assay study 152
Muscarinic cholinergic receptor subtypes in cerebral cortex of Fisher 344 rats: a light microscope autoradiography study of age-related changes. 152
Imidazoline receptors: Qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity 152
ALPHA1-ADRENERGIC RECEPTOR SUBTYPES HUMAN PERIPHERAL BLOOD LYMPHOCYTES 151
Expression of peripheral blood lymphocyte muscarinic cholinergic receptor subtypes in airway hyperresponsiveness 151
The dopaminergic system in hypertension 150
TREATMENT WITH A CHOLINERGIC PRECURSOR IN AN ANIMAL MODEL OF CEREBROVASCULAR DISEASE: INSIGHTS INTO MECHANISMS OF NEUROPROTECTIVE ACTIVITY 149
ACETYLCHOLINE PRECURSORS ATTENUATE NEUROINFLAMMATION IN LPS-STIMULATED BV2 CELLS 148
Neuroprotective Activity of Thioctic Acid in Central Nervous System Lesions Consequent to Peripheral Nerve Injury 148
Member of SCIENTIFIC ADVISORY BOARD of 9th International Congress on Vascular Dementia 148
Anti-Inflammatory and Antioxidant Properties of Tart Cherry Consumption in the Heart of Obese Rats 146
Muscarinic cholinergic receptor subtypes in the hippocampus of aged rats. 146
Totale 21.549
Categoria #
all - tutte 192.176
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 192.176


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.320 0 0 0 0 0 334 646 102 530 257 825 626
2021/20222.957 110 784 86 149 257 126 76 216 295 240 222 396
2022/20233.537 456 115 113 418 399 505 55 245 678 226 222 105
2023/20242.984 472 157 196 80 158 234 127 137 390 127 104 802
2024/202510.367 490 292 1.205 789 263 482 930 2.406 709 759 475 1.567
2025/20267.009 742 1.892 995 1.836 1.312 232 0 0 0 0 0 0
Totale 44.376